Prosperity Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,124
Closed -$207K 202
2025
Q3
$207K Sell
8,124
-1,527
-16% -$37.7K 0.08% 166
2025
Q2
$234K Buy
9,651
+69
+0.7% +$1.61K 0.1% 144
2025
Q1
$243K Buy
9,582
+800
+9% +$20.9K 0.12% 132
2024
Q4
$233K Sell
8,782
-517
-6% -$14K 0.12% 142
2024
Q3
$269K Sell
9,299
-56
-0.6% -$1.63K 0.15% 118
2024
Q2
$262K Buy
9,355
+123
+1% +$3.39K 0.17% 113
2024
Q1
$256K Buy
9,232
+1,868
+25% +$51.8K 0.16% 117
2023
Q4
$212K Sell
7,364
-930
-11% -$28.1K 0.15% 118
2023
Q3
$275K Sell
8,294
-525
-6% -$18.6K 0.23% 85
2023
Q2
$323K Buy
8,819
+2,012
+30% +$78.3K 0.28% 82
2023
Q1
$278K Buy
6,807
+262
+4% +$11.3K 0.28% 74
2022
Q4
$335K Buy
+6,545
New +$314K 0.36% 57

Other funds holding PFE

Prosperity Financial Group's PFE Position: Q4 2025 in Review

Prosperity Financial Group sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,124 shares — an estimated $207K sold.

Prosperity Financial Group first reported a position in PFE in Q4 2022 and held it in 12 quarters. The position peaked at $335K in Q4 2022. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Prosperity Financial Group reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Prosperity Financial Group sold 8,124 Pfizer shares in Q4 2025, an estimated $207K.
  • Prosperity Financial Group first reported a position in Pfizer in Q4 2022 and held it in 12 quarters.
  • Prosperity Financial Group's Pfizer position peaked at $335K in Q4 2022.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Prosperity Financial Group's 13F filing for Q4 2025, filed 26 Jan 2026.